Improvement of EGFR Testing over the Last Decade and Impact of Delaying TKI Initiation

Background: Epidermal growth factor receptor (EGFR) is the most common oncogenic mutation in lung adenocarcinoma and tyrosine kinase inhibitors (TKIs) have been considered standard treatment for more than a decade. However, time to initiation of TKIs (TTIT) from diagnosis is often delayed and repres...

Descripción completa

Detalles Bibliográficos
Autores principales: Blanc-Durand, Félix, Florescu, Marie, Tehfe, Mustapha, Routy, Bertrand, Alameddine, Raafat, Tran-Thanh, Danh, Blais, Normand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025752/
https://www.ncbi.nlm.nih.gov/pubmed/33652831
http://dx.doi.org/10.3390/curroncol28020102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025752/
https://www.ncbi.nlm.nih.gov/pubmed/33652831
http://dx.doi.org/10.3390/curroncol28020102

Ejemplares similares